Drug Survival and Long-term Outcome of Tofacitinib in Patients with Alopecia Areata: A Retrospective Study

Drug Survival and Long-term Outcome of Tofacitinib in Patients with Alopecia Areata: A Retrospective Study

Several non-randomized clinical trials and retrospective studies have demonstrated encouraging efficacy and well-tolerated safety of tofacitinib in the treatment of alopecia areata. However, there are scarce data on a large cohort of patients with alopecia areata in long-term real-world practice. Th...

Full description

Bibliographic Details
Main Authors:	Jundong Huang, Sihan Deng, Ji Li, Yan Tang, Fangfen Liu, Yu Liu, Shijia Rao, Wei Shi
Format:	Article
Language:	English
Published:	Medical Journals Sweden 2023-11-01
Series:	Acta Dermato-Venereologica
Subjects:	Alopecia Areata Tofacitinib JAK inhibitor Drug Survival effectiveness
Online Access:	https://medicaljournalssweden.se/actadv/article/view/13475

Similar Items

Characteristics and Outcomes of Patients on Tofacitinib for Alopecia Areata or Rheumatoid Arthritis: A Retrospective Cohort Study
by: Sarah Choe, et al.
Published: (2024-01-01)

Tofacitinib in a Recalcitrant Case of Alopecia Areata
by: Mansi Pithadia, et al.
Published: (2022-12-01)

Transient Efficacy of Tofacitinib in Alopecia Areata Universalis
by: Florian Anzengruber, et al.
Published: (2016-04-01)

Short-term efficacy and safety of tofacitinib in the treatment of alopecia areata
by: Zuyan WANG, et al.
Published: (2024-02-01)

Effectiveness and Predictive Factors of Response to Tofacitinib Therapy in 125 Patients with Alopecia Areata: A Single-centre Real-world Retrospective Study
by: Jundong Huang, et al.
Published: (2023-12-01)

An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
by: Rachel Berbert Ferreira, et al.
Published: (2019-12-01)

Clinical response to oral tofacitinib in pediatric patients with alopecia areata
by: Soundos Youssef, MD, et al.
Published: (2023-01-01)

Effectiveness of Tofacitinib in Pre-adolescent Alopecia Areata: A Retrospective Case Series and Literature Review
by: Jundong Huang, et al.
Published: (2023-09-01)

Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib
by: Ji Su Lee, et al.
Published: (2018-11-01)

The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
by: Diqin Yan, et al.
Published: (2022-08-01)

Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
by: Dongfan Wei, et al.
Published: (2023-04-01)

Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
by: Wenxin Zhang, et al.
Published: (2022-06-01)

Sisaipho alopecia areata treated with tofacitinib and oral minoxidil
by: Ronan Talty, BS, et al.
Published: (2022-11-01)

Insights, current status and future perspective of JAK inhibitors in the treatment of alopecia areata
by: Xingqi ZHANG
Published: (2022-04-01)

Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
by: He X, et al.
Published: (2024-03-01)

Survey of pediatric dermatologist views on treatment for alopecia areata
by: David Bitterman, BA, et al.
Published: (2023-12-01)

Acne exacerbation after tofacitinib treatment for alopecia areata
by: Sawsan Alharthi, et al.
Published: (2021-10-01)

Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
by: Kabir Sardana, et al.
Published: (2023-01-01)

Efficacy and safety of JAK inhibitors in the treatment of alopecia areata in children: a systematic review and meta-analysis
by: Yi Chen, et al.
Published: (2022-11-01)

Efficacy, safety, and Pharmacoeconomics of Three Common Strategies for Pediatric Alopecia Areata Patients: A Retrospective Cohort Study
by: Zhou J, et al.
Published: (2023-10-01)

Effective use of oral tofacitinib and phototherapy in a patient with concomitant alopecia areata, vitiligo, and plaque and inverse psoriasis
by: Mahroo Tajalli, et al.
Published: (2020-05-01)

Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date
by: Sofia Faria, et al.
Published: (2023-09-01)

Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
by: Leah Alexandra Johnston, BSc, MD, et al.
Published: (2023-05-01)

Clinical response to adjunctive platelet-rich plasma injections in a patient with alopecia universalis on oral tofacitinib
by: Sophia A. Ederaine, BA, et al.
Published: (2022-02-01)

At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
by: Katerina Yale, MD, et al.
Published: (2020-05-01)

Gut instinct: Using tofacitinib to treat alopecia areata in the context of comorbid inflammatory bowel disease
by: Danielle M. Peterson, MD, et al.
Published: (2021-01-01)

Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib—A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata
by: Kinga Kołcz, et al.
Published: (2023-01-01)

Alopecia areata: from pathophysiology to therapeutic innovation
by: Nuno Lourenço, et al.
Published: (2023-04-01)

Dupliumab therapy for alopecia areata: a case series and review of the literature
by: Jundong Huang, et al.
Published: (2024-12-01)

Spontaneous complete resolution of alopecia totalis post SARS-CoV-2 infection
by: Georgio Chidiac, MD, et al.
Published: (2022-09-01)

Editorial: Advances in evaluation and management of hair loss disorders
by: Manuel Valdebran, et al.
Published: (2023-01-01)

Inhibition of T-cell activity in alopecia areata: recent developments and new directions
by: Thierry Passeron, et al.
Published: (2023-11-01)

An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
by: Maddison Lensing, et al.
Published: (2022-08-01)

Alopecia areata universal
by: Edna Gabriela Delgado Quiñones, et al.

Perinevoid alopecia: an unusual presentation of alopecia areata
by: Jose Leonardo Rodrigues Machado, et al.
Published: (2022-07-01)

Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
by: Olivia Katamanin, BS, et al.
Published: (2024-01-01)

Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
by: Farnam Barati Sedeh, et al.
Published: (2023-01-01)

Alopecia areata: Treatment options
by: E. Kasumagić-Halilović, et al.
Published: (2006-02-01)

CORTICOSTEROID AS TREATMENT OF ALOPECIA AREATA
by: Ni Putu Junika Putri, et al.
Published: (2013-04-01)

Role of janus kinase inhibitors in the treatment of alopecia areata
by: Triyangkulsri K, et al.
Published: (2018-07-01)